Like many other countries, concerns regarding the safety and efficacy of COVID-19 vaccines, as well as myths and misinformation, have been spreading fast on social media in Kenya. The many cases of adverse side effects that were reported in Europe and the United States of America including the wide suspension of the use of the AstraZeneca vaccine for reports that it caused blood clots posed a major challenge in the trust of this vaccine by the general public. AstraZeneca is currently the only available vaccine in Kenya. Pharmacy and Poisons Board (PPB) announced in April that 279 people had suffered adverse effects after taking the Oxford-AstraZeneca coronavirus vaccine. After some hours, the board later recanted and said that "there was a misreporting of an adverse event following immunization (AEFI) as fatal. These kinds of doublespeak by the authorities are obviously not taken lightly by Kenyans.